GoldenTree Amends Bausch Health Stake, Passive Investment Noted

TL;DR

**GoldenTree updated its Bausch Health stake, showing a passive investment.**

AI Summary

GoldenTree Asset Management LP, a New York-based investment firm, filed an amended Schedule 13G/A on February 13, 2024, indicating a change in their ownership of Bausch Health Companies Inc. common shares as of December 31, 2023. This amendment, filed under Rule 13d-1(c), updates their previous disclosure regarding their passive investment in the pharmaceutical company. This matters to investors because it provides transparency into significant institutional holdings and any shifts in their positions, which can influence market sentiment and the stock's perceived stability.

Why It Matters

Changes in institutional ownership can signal shifts in confidence or strategy, potentially impacting Bausch Health's stock price and investor perception.

Risk Assessment

Risk Level: low — This filing is an amendment to a passive investment, indicating no immediate aggressive action or significant new risk.

Analyst Insight

Investors should note GoldenTree's continued passive stake in Bausch Health, but without specific share count changes in this excerpt, it's hard to gauge the exact impact. Further analysis of the full filing would be needed to determine if their position increased or decreased.

Key Players & Entities

• GoldenTree Asset Management LP (company) — the investment firm filing the SC 13G/A
• Bausch Health Companies Inc. (company) — the subject company whose shares are being reported
• December 31, 2023 (date) — the date of the event requiring the filing
• Rule 13d-1(c) (other) — the specific SEC rule under which the filing was made

FAQ

Filing Documents

• formsc13ga.htm (SC 13G/A) — 127KB
• 0001493152-24-006102.txt ( ) — 129KB

From the Filing

SC 13G/A 1 formsc13ga.htm UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Bausch Health Companies Inc. (Name of Issuer) Common Shares (Title of Class of Securities) 071734107 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 071734107 Schedule 13G Page 1 of 7 1 Names of Reporting Persons GoldenTree Asset Management LP 2 Check the Appropriate Box if a Member of a Group (a) (b) 3 SEC Use Only 4 Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With 5 Sole Voting Power 0 6 Shared Voting Power 27,644,959 7 Sole Dispositive Power 0 8 Shared Dispositive Power 27,644,959 9 Aggregate Amount Beneficially Owned by Each Reporting Person 27,644,959 10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares Not Applicable 11 Percent of Class Represented by Amount in Row 9 7.6% 12 Type of Reporting Person PN CUSIP No. 071734107 Schedule 13G Page 2 of 7 1 Names of Reporting Persons GoldenTree Asset Management LLC 2 Check the Appropriate Box if a Member of a Group (a) (b) 3 SEC Use Only 4 Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With 5 Sole Voting Power 0 6 Shared Voting Power 27,644,959 7 Sole Dispositive Power 0 8 Shared Dispositive Power 27,644,959 9 Aggregate Amount Beneficially Owned by Each Reporting Person 27,644,959 10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares Not Applicable 11 Percent of Class Represented by Amount in Row 9 7.6% 12 Type of Reporting Person OO (Limited Liability company) CUSIP No. 071734107 Schedule 13G Page 3 of 7 1 Names of Reporting Persons Steven A. Tananbaum 2 Check the Appropriate Box if a Member of a Group (a) (b) 3 SEC Use Only 4 Citizenship or Place of Organization United Number of Shares Beneficially Owned by Each Reporting Person With 5 Sole Voting Power 802,685 6 Shared Voting Power 27,644,959 7 Sole Dispositive Power 802,685 8 Shared Dispositive Power 27,644,959 9 Aggregate Amount Beneficially Owned by Each Reporting Person 28,447,644 10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares Not Applicable 11 Percent of Class Represented by Amount in Row 9 7.8% 12 Type of Reporting Person IN CUSIP No. 071734107 Schedule 13G Page 4 of 7 ITEM 1. (a) Name of Issuer: Bausch Health Companies Inc. (the “Issuer”). (b) Address of Issuer’s Principal Executive Offices: 2150 St. Elzéar Blvd. West, Laval, Québec, Canada H7L 4A8. ITEM 2. (a) Name of Person Filing: Each of the following is hereinafter individually referred to as a “Reporting Person” and collectively as the “Reporting Persons.” This statement is filed on behalf of: GoldenTree Asset Management LP (the “Investment Manager”) GoldenTree Asset Management LLC (“IMGP”) Steven A. Tananbaum (b) Address or Principal Business Office: The principal business address of each of the Reporting Persons is 300 Park Avenue, 21st Floor, New York, NY 10022. (c) Citizenship of each Reporting Person is: Investment Manager and IMGP are organized under the laws of the State of Delaware. Mr. Tananbaum is a citizen of the United States. (d) Title of Class of Securities: Common Shares, no par value (“Common Shares”). (e) CUSIP Number: 071734107 ITEM 3. Not applicable. CUSIP No. 071734107 Schedule 13G Page 5 of 7 ITEM 4. Ownership. (a-c) The 365,195,048 Common Shares outstanding as of October 27, 2023, based on the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 2, 2023. Reporting Person Amount beneficially o

View Full Filing

View this SC 13G/A filing on SEC EDGAR